about
Trospium chloride treatment of overactive bladderDrug Insight: biological effects of botulinum toxin A in the lower urinary tract.Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder.Alpha1-Adrenoceptor Antagonists Improve Memory by Activating N-methyl-D-Aspartate-Induced Ion Currents in the Rat HippocampusSolifenacin provides effective antimuscarinic therapy for the complete management of overactive bladder.Pharmacologic management of overactive bladder.Obstructive sleep apnea syndrome is associated with overactive bladder and urgency incontinence in men.Social, economic, and health utility considerations in the treatment of overactive bladder.Heart rate variability in overactive bladder experimental model.Effects of Combination Treatment of Alpha 1-Adrenergic Receptor Antagonists on Voiding Dysfunction: Study on Target Organs in Overactive Bladder Rats.ADX71441, a novel, potent and selective positive allosteric modulator of the GABA(B) receptor, shows efficacy in rodent models of overactive bladder.Anticholinergics for overactive bladder therapy: central nervous system effects.Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder.Influence of estrogen replacement and aging on the expression of nerve growth factor in the urethra of female rats.Tolterodine ER reduced increased bladder wall thickness in women with overactive bladder. A randomized, placebo-controlled, double-blind, parallel group study.Sociocultural and environmental influences on bladder health.Anorectal manometry evaluation in adult women with clinical and urodynamic diagnostics of overactive bladder.Overactive bladder syndrome and bladder wall thickness in patients with obstructive sleep apnea syndrome.Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.Underactive bladder: Pathophysiology and clinical significance.Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways
P2860
Q28308162-6BC4729D-52C7-468B-B61D-B41290D6908AQ35057523-AB103F8E-6FC2-48A7-96B9-370421340696Q35875533-A9141082-2399-4CE9-BCE0-CBD047829ED8Q36438248-E1481406-148B-48F0-A2DC-01825FA1D37BQ36655193-03DC1C7C-3A16-45E2-A1B3-708451FF4477Q37017434-E3CB157E-0C6B-47E0-8174-DC9F6CE4765EQ37083185-BAF1AA82-797D-4A76-A6C2-510E75C879A1Q37283547-24B17A15-3006-482D-ADD2-E4F00B7366F9Q37321858-5C6211CE-4B48-41E9-95BF-1FE74C0982D4Q37517854-6DA4C61D-187E-43CB-BAF0-C59447A4E504Q37585413-EF4652F9-BFC3-46D5-8061-4CF47B4F13C5Q37954372-3326734A-429E-4CF1-951A-12B2CDA87ADCQ37990531-1CE2CD9E-98CC-44BD-B07E-1FDEBCFE4827Q40032339-094F7FD1-2D23-4D3C-9857-0D7FE2BC3975Q40243546-DDA7BC42-F034-46B5-AFD2-9D0B223313E7Q43351741-D8759DAB-BDDD-40F6-BAAF-60636B03BFF2Q44511241-AB9E7BFE-CACA-445D-91BC-D3A344D84221Q47662985-D8B72C3B-AADE-482F-B723-0916EA25D4EEQ51539014-CCB04983-1530-4FE1-9FC6-248063A283DFQ52703021-0C1AAFE4-B9AA-4024-A298-A58FEC23383BQ57565136-2ABC5463-078F-4F8F-A662-F71F8132A92E
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pathophysiology of overactive bladder.
@ast
Pathophysiology of overactive bladder.
@en
type
label
Pathophysiology of overactive bladder.
@ast
Pathophysiology of overactive bladder.
@en
prefLabel
Pathophysiology of overactive bladder.
@ast
Pathophysiology of overactive bladder.
@en
P1476
Pathophysiology of overactive bladder.
@en
P2093
Franklin M Chu
P356
10.1016/J.AMJMED.2005.12.010
P407
P433
P577
2006-03-01T00:00:00Z